Skip to main content

Advertisement

Table 1 Effects of RSVL treatment (10 mg/kg,i.p.) on the therapeutic action of DOX (15 mg/kg,i.p.) in mice bearing Ehrlich ascites carcinoma cells

From: Chemosensetizing and cardioprotective effects of resveratrol in doxorubicin- treated animals

Treatment Mean survival time 45-day survivors
Control 15 ± 4.06 a, b 0/10
RSVL (10 mg/kg) 13 ± 3.55 b 0/10
DOX (15 mg/kg) 21 ± 9.19 a, b 1/10
DOX (15 mg/kg) + RSVL (10 mg/kg) (supplied simultaneously) 30 ± 5.29 a, b 7/10
  1. Each data represents the mean ± S.D. of ten mice. The mean Survival time is the time in days until animals die.
  2. aSignificantly different from control at P-value ≤ 0.05. bSignificantly different from DOX at P-value ≤ 0.05.